Ototopical Ciprofloxacin in a Glycerin Vehicle for the Treatment of Acute External Otitis

We conducted a prospective, randomized, controlled, double-blind study of 33 patients to compare the efficacy and tolerability of a new glycerin formulation of ototopical 0.3% ciprofloxacin with that of a conventional aqueous formulation of ciprofloxacin for the treatment of acute external otitis. O...

Full description

Saved in:
Bibliographic Details
Published in:Ear, nose, & throat journal nose, & throat journal, 2004-09, Vol.83 (9), p.625-638
Main Authors: Olivera, María E., Bistoni, Adriana, Anun, Hugo E., Salinas, Aquiles, Manzo, Ruben H.
Format: Article
Language:English
Subjects:
Acute Disease
Administration, Topical
Adolescent
Adult
Aged
Aged, 80 and over
Anti-Infective Agents - administration & dosage
Anti-Infective Agents - therapeutic use
Child
Ciprofloxacin - administration & dosage
Ciprofloxacin - therapeutic use
Double-Blind Method
Ear
Female
Glycerol - administration & dosage
Humans
Inflammation
Male
Medical research
Medicine, Experimental
Middle Aged
Otitis Media - drug therapy
Pharmaceutical Vehicles
Prospective Studies
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We conducted a prospective, randomized, controlled, double-blind study of 33 patients to compare the efficacy and tolerability of a new glycerin formulation of ototopical 0.3% ciprofloxacin with that of a conventional aqueous formulation of ciprofloxacin for the treatment of acute external otitis. Outcomes measures were resolution of discharge, swelling, pain, and redness and the incidence of adverse side effects. Patients were examined on three occasions: on the day of enrollment (visit 1), 48 to 72 hours later (visit 2), and 7 days after enrollment (visit 3). At visit 2, the patients in the glycerin group showed a significantly greater resolution of discharge. We observed the same pattern with respect to swelling, pain, and redness, which resolved more quickly in the glycerin group, although not significantly so. All patients were cured by visit 3, and the two treatments were equally well tolerated. On the basis of our findings, we conclude that the glycerin formulation of ototopical 0.3% ciprofloxacin appears to be at least as effective as the aqueous form in the treatment of acute external otitis—and in the case of otorrhea, more so.
ISSN:0145-5613
1942-7522
DOI:10.1177/014556130408300912